科博达股票讨论区

Investors are justifying KEBODA TECHNOLOGY's high P/E ratio due to its superior earnings outlook. Despite risks, potential for substantial earnings decline is low, with no major foreseen drop in share price.

The COVID-19 infection rate has peaked in major Chinese cities (such as Beijing, Shanghai, Guangzhou, Shenzhen, and so on.) The number of COVID-19 infections has begun to fall from a high level. What is the progress of the current consumer market recovery now?
How to grasp the investment opportunities in the consumer sector in 2023?
[Food & Beauty]Infection peak has passed. Consumer recovery ahead
Infections...